Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

UK Pain Patch Market

ID: MRFR/HC/49538-HCR
200 Pages
Vikita Thakur
Last Updated: March 28, 2026

UK Pain Patch Market Research Report: By Application (Chronic Pain Relief, Acute Pain Relief, Muscle Pain Relief, Joint Pain Relief, Post-operative Pain Relief), By Product Type (Heat Patch, Cold Patch, Medicated Patch, Herbal Patch, Transdermal Patch), By End User (Hospitals, Clinics, Home Care, Pharmacies, Sports Facilities) andBy Distribution Channel (Online, Offline, Pharmacies, Supermarkets, Specialty Stores)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

UK Pain Patch Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 UK Pain Patch Market, BY Application (USD Billion)
  49.     4.1.1 Chronic Pain
  50.     4.1.2 Acute Pain
  51.     4.1.3 Postoperative Pain
  52.     4.1.4 Muscle Pain
  53.   4.2 UK Pain Patch Market, BY Type (USD Billion)
  54.     4.2.1 Transdermal Patch
  55.     4.2.2 Topical Patch
  56.     4.2.3 Herbal Patch
  57.     4.2.4 Medicated Patch
  58.   4.3 UK Pain Patch Market, BY Distribution Channel (USD Billion)
  59.     4.3.1 Pharmacies
  60.     4.3.2 Online Retail
  61.     4.3.3 Supermarkets
  62.     4.3.4 Health Stores
  63.   4.4 UK Pain Patch Market, BY End User (USD Billion)
  64.     4.4.1 Hospitals
  65.     4.4.2 Clinics
  66.     4.4.3 Home Care
  67.     4.4.4 Rehabilitation Centers
  68. 5 SECTION V: COMPETITIVE ANALYSIS
  69.   5.1 Competitive Landscape
  70.     5.1.1 Overview
  71.     5.1.2 Competitive Analysis
  72.     5.1.3 Market share Analysis
  73.     5.1.4 Major Growth Strategy in the UK Pain Patch Market
  74.     5.1.5 Competitive Benchmarking
  75.     5.1.6 Leading Players in Terms of Number of Developments in the UK Pain Patch Market
  76.     5.1.7 Key developments and growth strategies
  77.       5.1.7.1 New Product Launch/Service Deployment
  78.       5.1.7.2 Merger & Acquisitions
  79.       5.1.7.3 Joint Ventures
  80.     5.1.8 Major Players Financial Matrix
  81.       5.1.8.1 Sales and Operating Income
  82.       5.1.8.2 Major Players R&D Expenditure. 2023
  83.   5.2 Company Profiles
  84.     5.2.1 Johnson & Johnson (GB)
  85.       5.2.1.1 Financial Overview
  86.       5.2.1.2 Products Offered
  87.       5.2.1.3 Key Developments
  88.       5.2.1.4 SWOT Analysis
  89.       5.2.1.5 Key Strategies
  90.     5.2.2 Bayer AG (DE)
  91.       5.2.2.1 Financial Overview
  92.       5.2.2.2 Products Offered
  93.       5.2.2.3 Key Developments
  94.       5.2.2.4 SWOT Analysis
  95.       5.2.2.5 Key Strategies
  96.     5.2.3 Pfizer Inc. (US)
  97.       5.2.3.1 Financial Overview
  98.       5.2.3.2 Products Offered
  99.       5.2.3.3 Key Developments
  100.       5.2.3.4 SWOT Analysis
  101.       5.2.3.5 Key Strategies
  102.     5.2.4 Novartis AG (CH)
  103.       5.2.4.1 Financial Overview
  104.       5.2.4.2 Products Offered
  105.       5.2.4.3 Key Developments
  106.       5.2.4.4 SWOT Analysis
  107.       5.2.4.5 Key Strategies
  108.     5.2.5 GlaxoSmithKline plc (GB)
  109.       5.2.5.1 Financial Overview
  110.       5.2.5.2 Products Offered
  111.       5.2.5.3 Key Developments
  112.       5.2.5.4 SWOT Analysis
  113.       5.2.5.5 Key Strategies
  114.     5.2.6 Mylan N.V. (GB)
  115.       5.2.6.1 Financial Overview
  116.       5.2.6.2 Products Offered
  117.       5.2.6.3 Key Developments
  118.       5.2.6.4 SWOT Analysis
  119.       5.2.6.5 Key Strategies
  120.     5.2.7 Haleon plc (GB)
  121.       5.2.7.1 Financial Overview
  122.       5.2.7.2 Products Offered
  123.       5.2.7.3 Key Developments
  124.       5.2.7.4 SWOT Analysis
  125.       5.2.7.5 Key Strategies
  126.     5.2.8 Sanofi S.A. (FR)
  127.       5.2.8.1 Financial Overview
  128.       5.2.8.2 Products Offered
  129.       5.2.8.3 Key Developments
  130.       5.2.8.4 SWOT Analysis
  131.       5.2.8.5 Key Strategies
  132.     5.2.9 Teva Pharmaceutical Industries Ltd. (IL)
  133.       5.2.9.1 Financial Overview
  134.       5.2.9.2 Products Offered
  135.       5.2.9.3 Key Developments
  136.       5.2.9.4 SWOT Analysis
  137.       5.2.9.5 Key Strategies
  138.   5.3 Appendix
  139.     5.3.1 References
  140.     5.3.2 Related Reports
  141. 6 LIST OF FIGURES
  142.   6.1 MARKET SYNOPSIS
  143.   6.2 UK MARKET ANALYSIS BY APPLICATION
  144.   6.3 UK MARKET ANALYSIS BY TYPE
  145.   6.4 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  146.   6.5 UK MARKET ANALYSIS BY END USER
  147.   6.6 KEY BUYING CRITERIA OF UK PAIN PATCH MARKET
  148.   6.7 RESEARCH PROCESS OF MRFR
  149.   6.8 DRO ANALYSIS OF UK PAIN PATCH MARKET
  150.   6.9 DRIVERS IMPACT ANALYSIS: UK PAIN PATCH MARKET
  151.   6.10 RESTRAINTS IMPACT ANALYSIS: UK PAIN PATCH MARKET
  152.   6.11 SUPPLY / VALUE CHAIN: UK PAIN PATCH MARKET
  153.   6.12 UK PAIN PATCH MARKET, BY APPLICATION, 2024 (% SHARE)
  154.   6.13 UK PAIN PATCH MARKET, BY APPLICATION, 2024 TO 2035 (USD Billion)
  155.   6.14 UK PAIN PATCH MARKET, BY TYPE, 2024 (% SHARE)
  156.   6.15 UK PAIN PATCH MARKET, BY TYPE, 2024 TO 2035 (USD Billion)
  157.   6.16 UK PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
  158.   6.17 UK PAIN PATCH MARKET, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
  159.   6.18 UK PAIN PATCH MARKET, BY END USER, 2024 (% SHARE)
  160.   6.19 UK PAIN PATCH MARKET, BY END USER, 2024 TO 2035 (USD Billion)
  161.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  162. 7 LIST OF TABLES
  163.   7.1 LIST OF ASSUMPTIONS
  164.     7.1.1
  165.   7.2 UK MARKET SIZE ESTIMATES; FORECAST
  166.     7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  167.     7.2.2 BY TYPE, 2026-2035 (USD Billion)
  168.     7.2.3 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Billion)
  169.     7.2.4 BY END USER, 2026-2035 (USD Billion)
  170.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  171.     7.3.1
  172.   7.4 ACQUISITION/PARTNERSHIP
  173.     7.4.1

UK Pain Patch Market Segmentation

UK Pain Patch Market By Application (USD Billion, 2022-2035)

  • Chronic Pain
  • Acute Pain
  • Postoperative Pain
  • Muscle Pain

UK Pain Patch Market By Type (USD Billion, 2022-2035)

  • Transdermal Patch
  • Topical Patch
  • Herbal Patch
  • Medicated Patch

UK Pain Patch Market By Distribution Channel (USD Billion, 2022-2035)

  • Pharmacies
  • Online Retail
  • Supermarkets
  • Health Stores

UK Pain Patch Market By End User (USD Billion, 2022-2035)

  • Hospitals
  • Clinics
  • Home Care
  • Rehabilitation Centers

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions